Eton Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Eton Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Eton Pharmaceuticals Inc
Rating: 1.880249875
Author: Trendlyne DVM scores

Momentum Trap

about

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCR...

29.96 -0.86 (-2.79%)

129.05% Gain from 52W Low

444.2K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for Eton Pharma Inc took place on 14 May 2026, for the purpose of Eton Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 See details

Low Financial Strength

33.3 / 100

Expensive Valuation

9.3 / 100

Technically Bullish

74.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 37%

3 analysts

Eton Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Eton Pharma Inc Live Stock Price Today, Share Analysis and Chart

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCR...

129.05% Gain from 52W Low

SWOT Analysis

Eton Pharma Inc Live Price Chart